Apogee Therapeutics Statistics
Total Valuation
APGE has a market cap or net worth of $2.17 billion. The enterprise value is $1.45 billion.
Important Dates
The last earnings date was Monday, March 3, 2025, before market open.
Earnings Date | Mar 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APGE has 58.09 million shares outstanding. The number of shares has increased by 120.73% in one year.
Current Share Class | 44.60M |
Shares Outstanding | 58.09M |
Shares Change (YoY) | +120.73% |
Shares Change (QoQ) | +0.80% |
Owned by Insiders (%) | 2.16% |
Owned by Institutions (%) | 86.67% |
Float | 39.04M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.03 |
P/TBV Ratio | 3.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.55, with a Debt / Equity ratio of 0.02.
Current Ratio | 18.55 |
Quick Ratio | 18.39 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.22% and return on invested capital (ROIC) is -24.41%.
Return on Equity (ROE) | -33.22% |
Return on Assets (ROA) | -23.46% |
Return on Invested Capital (ROIC) | -24.41% |
Return on Capital Employed (ROCE) | -29.90% |
Revenue Per Employee | n/a |
Profits Per Employee | -$929,316 |
Employee Count | 196 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, APGE has paid $18,000 in taxes.
Income Tax | 18,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.78% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -43.78% |
50-Day Moving Average | 37.59 |
200-Day Moving Average | 45.62 |
Relative Strength Index (RSI) | 46.77 |
Average Volume (20 Days) | 778,138 |
Short Selling Information
The latest short interest is 8.16 million, so 14.05% of the outstanding shares have been sold short.
Short Interest | 8.16M |
Short Previous Month | 7.76M |
Short % of Shares Out | 14.05% |
Short % of Float | 20.91% |
Short Ratio (days to cover) | 10.72 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -216.87M |
Pretax Income | -103.55M |
Net Income | -182.15M |
EBITDA | -216.68M |
EBIT | -216.87M |
Earnings Per Share (EPS) | -$3.30 |
Full Income Statement Balance Sheet
The company has $520.65 million in cash and $11.83 million in debt, giving a net cash position of $719.24 million or $12.38 per share.
Cash & Cash Equivalents | 520.65M |
Total Debt | 11.83M |
Net Cash | 719.24M |
Net Cash Per Share | $12.38 |
Equity (Book Value) | 716.79M |
Book Value Per Share | 12.35 |
Working Capital | 501.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$171.17 million and capital expenditures -$1.15 million, giving a free cash flow of -$172.33 million.
Operating Cash Flow | -171.17M |
Capital Expenditures | -1.15M |
Free Cash Flow | -172.33M |
FCF Per Share | -$2.97 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |